Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data

Title
Specific antidotes against direct oral anticoagulants: A comprehensive review of clinical trials data
Authors
Keywords
Idarucizumab, Andexanet alfa, DOAC, NOAC, Dabigatran, Rivaroxaban, Apixaban, Edoxaban, Antidote, Praxbind, ANNEXA-A, ANNEXA-R
Journal
INTERNATIONAL JOURNAL OF CARDIOLOGY
Volume 214, Issue -, Pages 292-298
Publisher
Elsevier BV
Online
2016-03-29
DOI
10.1016/j.ijcard.2016.03.056

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started